{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:14:40Z","timestamp":1790511280229,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T00:00:00Z","timestamp":1601164800000},"content-version":"vor","delay-in-days":1792,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA-140416"],"award-info":[{"award-number":["R01-CA-140416"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1074\/jbc.m115.665133","type":"journal-article","created":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T02:38:37Z","timestamp":1442889517000},"page":"27473-27486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells"],"prefix":"10.1016","volume":"290","author":[{"given":"Stuti","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Rothbart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M115.665133_bib1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signaling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.665133_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.98.1.136","article-title":"A role of the kinase mTOR in cellular transformation induced by the oncoproteins PI3k and Akt","volume":"98","author":"Aoki","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.665133_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M115.665133_bib4","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1200\/JCO.2004.02.141","article-title":"The biology and clinical relevance of the PTEN tumor suppressor pathway","volume":"22","author":"Sansal","year":"2004","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/jbc.M115.665133_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0960-9822(03)00329-4","article-title":"TOS motif-mediated Raptor binding regulates 4E-BP1 multisite phosphorylation and function","volume":"13","author":"Schalm","year":"2003","journal-title":"Curr. Biol"},{"key":"10.1074\/jbc.M115.665133_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.665133_bib7","doi-asserted-by":"crossref","first-page":"15461","DOI":"10.1074\/jbc.C200665200","article-title":"The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif","volume":"278","author":"Nojima","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.665133_bib8","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1200\/JCO.2009.25.3641","article-title":"The PI3K pathway as a drug target in human cancer","volume":"28","author":"Courtney","year":"2010","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/jbc.M115.665133_bib9","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1158\/0008-5472.CAN-09-4355","article-title":"Drugging the PI3 kinome: from chemical tools to drugs in the clinic","volume":"70","author":"Workman","year":"2010","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M115.665133_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2010.01.021","article-title":"Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E","volume":"17","author":"Hsieh","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.M115.665133_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ccr.2006.10.003","article-title":"A negative feedback signaling network underlies oncogene-induced senescence","volume":"10","author":"Courtois-Cox","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.M115.665133_bib12","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O'Reilly","year":"2006","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M115.665133_bib13","first-page":"3065","article-title":"Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer","volume":"118","author":"Carracedo","year":"2008","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M115.665133_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","article-title":"PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer","volume":"19","author":"Chandarlapaty","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.M115.665133_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M115.665133_bib16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","article-title":"PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase","volume":"25","author":"Sancak","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.M115.665133_bib17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/jbc.M115.665133_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumour suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/Akt pathway","volume":"10","author":"Manning","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.M115.665133_bib19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.M115.665133_bib20","doi-asserted-by":"crossref","first-page":"R251","DOI":"10.1093\/hmg\/ddi260","article-title":"Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways","volume":"15","author":"Kwiatkowski","year":"2005","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.M115.665133_bib21","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signaling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/jbc.M115.665133_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.M115.665133_bib23","doi-asserted-by":"crossref","first-page":"27879","DOI":"10.1074\/jbc.271.44.27879","article-title":"Characterization of the AMP-activated protein kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase","volume":"271","author":"Hawley","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.665133_bib24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.biochem.67.1.821","article-title":"The AMP-activated\/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?","volume":"67","author":"Hardie","year":"1998","journal-title":"Annu. Rev. Biochem"},{"key":"10.1074\/jbc.M115.665133_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.665133_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.M115.665133_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cell.2008.06.028","article-title":"p53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling","volume":"134","author":"Budanov","year":"2008","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.665133_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","article-title":"Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids","volume":"141","author":"Sancak","year":"2010","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.665133_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2013.11.049","article-title":"Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome","volume":"156","author":"Menon","year":"2014","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.665133_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2014.09.014","article-title":"The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1","volume":"9","author":"Chantranupong","year":"2014","journal-title":"Cell Rep"},{"key":"10.1074\/jbc.M115.665133_bib31","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-06-4149","article-title":"The regulation of AMPK\u03b21, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways","volume":"67","author":"Feng","year":"2007","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M115.665133_bib32","article-title":"Deletion or hot-spot mutations of p53 enhance mTORC1 activity by changing the lysosomal partitioning of TSC2 and Rheb","author":"Agarwal","year":"2015","journal-title":"Mol. Cancer Res"},{"key":"10.1074\/jbc.M115.665133_bib33","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature07423","article-title":"Somatic mutations affect key pathways in lung adenocarcinoma","volume":"455","author":"Ding","year":"2008","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.665133_bib34","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.cub.2003.10.031","article-title":"LKB1 is the upstream kinase in the AMP-activated protein kinase cascade","volume":"13","author":"Woods","year":"2003","journal-title":"Curr. Biol"},{"key":"10.1074\/jbc.M115.665133_bib35","first-page":"3659","article-title":"Inactivation of LKB1\/STK11 is a common event in adenocarcinomas of the lung","volume":"62","author":"Sanchez-Cespedes","year":"2002","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M115.665133_bib36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1432-1033.1995.tb20498.x","article-title":"5-Aminoimidazole-4-carboxamide ribonucleoside: a specific method for activating AMP-activated protein kinase in intact cells","volume":"229","author":"Corton","year":"1995","journal-title":"Eur. J. Biochem"},{"key":"10.1074\/jbc.M115.665133_bib37","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cmet.2010.04.001","article-title":"Use of cells expressing \u03b3 subunit variants to identify diverse mechanisms of AMPK activation","volume":"11","author":"Hawley","year":"2010","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.M115.665133_bib38","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1158\/0008-5472.CAN-08-4979","article-title":"Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition","volume":"69","author":"Racanelli","year":"2009","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M115.665133_bib39","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1158\/0008-5472.CAN-10-1873","article-title":"Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas","volume":"70","author":"Rothbart","year":"2010","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M115.665133_bib40","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1021\/jm00101a023","article-title":"A dideazatetrahydrofolate analogue lacking a chiral center at C-6,N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3- d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid is an inhibitor of thymidylate synthase","volume":"35","author":"Taylor","year":"1992","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M115.665133_bib41","first-page":"1116","article-title":"LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes","volume":"57","author":"Shih","year":"1997","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M115.665133_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1476-4598-6-46","article-title":"Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-\u03b2-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy","volume":"6","author":"Sengupta","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1074\/jbc.M115.665133_bib43","doi-asserted-by":"crossref","first-page":"39582","DOI":"10.1074\/jbc.M507443200","article-title":"5-Aminoimidazole-4-carboxamide-1-\u03b2-d-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase","volume":"280","author":"Rattan","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.665133_bib44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrm2395","article-title":"Transcriptional control of human p53-regulated genes","volume":"9","author":"Riley","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.M115.665133_bib45","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1101\/gad.11.24.3471","article-title":"DNA damage induces phosphorylation of the amino terminus of p53","volume":"11","author":"Siliciano","year":"1997","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.M115.665133_bib46","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1046\/j.1432-1327.2001.02225.x","article-title":"Post-translational modifications and activation of p53 by genotoxic stresses","volume":"268","author":"Appella","year":"2001","journal-title":"Eur. J. Biochem"},{"key":"10.1074\/jbc.M115.665133_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1101\/gad.14.3.289","article-title":"The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites","volume":"14","author":"Shieh","year":"2000","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.M115.665133_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ijc.28680","article-title":"Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019","volume":"135","author":"Vecchio","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.M115.665133_bib49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","article-title":"AMP-activated protein kinase induces a p53-dependent metabolic checkpoint","volume":"18","author":"Jones","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.M115.665133_bib50","doi-asserted-by":"crossref","first-page":"e1045","DOI":"10.1038\/cddis.2013.477","article-title":"Uracil DNA glycosylase (UNG) loss enhances DNA double strand break formation in human cancer cells exposed to pemetrexed","volume":"5","author":"Weeks","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1074\/jbc.M115.665133_bib51","unstructured":"Rothbart, S. B., (2010) Antifolate Modulators of AMP-activated Protein Kinase Signaling as Cancer Therapeutics. Doctoral dissertation, Virginia Commonwealth University, Richmond, VA,."},{"key":"10.1074\/jbc.M115.665133_bib52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cell.2005.10.024","article-title":"mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events","volume":"123","author":"Holz","year":"2005","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.665133_bib53","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1101\/gad.887201","article-title":"Regulation of translation initiation by FRAP\/mTOR","volume":"15","author":"Gingras","year":"2001","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.M115.665133_bib54","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cell.2014.08.038","article-title":"Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling","volume":"159","author":"Peng","year":"2014","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.665133_bib55","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1124\/jpet.109.154997","article-title":"Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]","volume":"331","author":"Jobson","year":"2009","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.M115.665133_bib56","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1128\/MCB.00447-06","article-title":"Phosphorylationof Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit","volume":"26","author":"Leung-Pineda","year":"2006","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.M115.665133_bib57","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1101\/gad.1795709","article-title":"A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint","volume":"23","author":"Beckerman","year":"2009","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.M115.665133_bib58","doi-asserted-by":"crossref","first-page":"21047","DOI":"10.1016\/S0021-9258(19)30043-2","article-title":"The 6S- and 6R-diastereomers of 5,10-dideaza-5,6,7,8-tetrahydrofolate are equiactive inhibitors of de novo purine synthesis","volume":"264","author":"Moran","year":"1989","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.665133_bib59","doi-asserted-by":"crossref","first-page":"47759","DOI":"10.1074\/jbc.C100569200","article-title":"Histone H2AX is phosphorylated in an ATR-dependent manner in response to replication stress","volume":"276","author":"Ward","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.665133_bib60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s002800050608","article-title":"Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostasis","volume":"39","author":"Tonkinson","year":"1997","journal-title":"Cancer Chemother. Pharmacol"},{"key":"10.1074\/jbc.M115.665133_bib61","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1158\/0008-5472.CAN-05-0917","article-title":"Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition","volume":"65","author":"Sun","year":"2005","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M115.665133_bib62","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1158\/1078-0432.CCR-03-0043","article-title":"Determinants of rapamycin sensitivity in breast cancer cells","volume":"10","author":"Noh","year":"2004","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.M115.665133_bib63","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1158\/1078-0432.CCR-04-0361","article-title":"Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells","volume":"10","author":"Mondesire","year":"2004","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.M115.665133_bib64","doi-asserted-by":"crossref","first-page":"48861","DOI":"10.1074\/jbc.M304844200","article-title":"A defect in the p53 response pathway induced by de novo purine synthesis inhibition","volume":"278","author":"Bronder","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.665133_bib65","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1073\/pnas.98.3.1036","article-title":"p53 accumulates but is functionally impaired when DNA synthesis is blocked","volume":"98","author":"Gottifredi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820439614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820439614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M115.665133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T13:17:26Z","timestamp":1641302246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820439614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":65,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0021925820439614"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m115.665133","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M115.665133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}